NDC 66479-530-02 - Methadone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66479-530
- Requested NDC
- 66479-530-02
- Package NDCs from labels
- 66479-530-02
- Manufacturer
- Xanodyne Pharmaceuticals Inc.
- Effective date
- 2007-10-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| METHADONE HYDROCHLORIDE INJECTION, USP | Xanodyne Pharmaceuticals Inc. | 2007-10-06 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66479-530-02 | Methadone | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 1 | |
| 66479-530-02 | Methadone | 1 in 1 PACKAGE | INJECTION, SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| methadone hydrochloride | ACTIVE INGREDIENT | 229809935B | METHADONE (METHADONE HYDROCHLORIDE) INJECTION, SOLUTION [XANODYNE PHARMACEUTICALS INC.] | 1 | |
| methadone | ACTIVE MOIETY | UC6VBE7V1Z | METHADONE (METHADONE HYDROCHLORIDE) INJECTION, SOLUTION [XANODYNE PHARMACEUTICALS INC.] | 1 | |
| chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | METHADONE (METHADONE HYDROCHLORIDE) INJECTION, SOLUTION [XANODYNE PHARMACEUTICALS INC.] | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | METHADONE (METHADONE HYDROCHLORIDE) INJECTION, SOLUTION [XANODYNE PHARMACEUTICALS INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methadone Hydrochloride | METHADONE HYDROCHLORIDE | Long Grove Pharmaceuticals, LLC | f453f1b9-d46e-4be8-835d-dbeb9d98a149 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 864714 |
| Methadone Hydrochloride | METHADONE HYDROCHLORIDE | Breckenridge Pharmaceutical Inc | 13541167-95f4-4cb9-9d7d-3c1aced5c5f6 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 864714 |
| Methadone Hydrochloride | METHADONE HYDROCHLORIDE | Mylan Institutional LLC | 092d78eb-6423-495c-bf0d-e6532bea7138 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 864714 |
| Methadone Hydrochloride | METHADONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 1a6dbcb0-68f2-4f8b-94ee-baa2aa296293 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | 864714 |
| 3DF4A22E-18AB-BEDA-263A-DB02D0BD7C5A | 9bbe219f-3bf1-44f4-a709-cd108c4fa9ef | 2007-10-06 | Boxed warning, Warnings, Adverse reactions | 3DF4A22E-18AB-BEDA-263A-DB02D0BD7C5A 9bbe219f-3bf1-44f4-a709-cd108c4fa9ef |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.